Telesis Bio, Inc.
Ribonucleic acids with 4'-thio-modified nucleotides and related methods

Last updated:

Abstract:

Disclosed are messenger RNA molecules and related compositions incorporating a 4'-thio modification in the furanose ring of at least one nucleotide residue, and methods of using these mRNAs to produce an encoded therapeutic protein in vivo and to treat or prevent diseases or disorders. In certain embodiments, the 4'-thio modified mRNA provides for enhanced stability and/or reduced immunogenicity in in vivo therapies.

Status:
Grant
Type:

Utility

Filling date:

25 Sep 2020

Issue date:

20 Sep 2022